GlassScriptPhysician profile
Murray P Whitaker
NPI 1053349373
$6,442.92
in general payments reported to CMS, 2019-2025
32 companies · $1,651 in 2025
The $1,651 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $401 · 2021: $844 · 2022: $934 · 2023: $1,032 · 2024: $988 · 2025: $1,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,670.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $780.26 | 2019-2025 | Gallant, Aveir, Jot Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $771.86 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $756.11 | 2019-2025 | Leqvio |
| Merck Sharp & Dohme LLC | $573.41 | 2021-2025 | Verquvo, Capvaxive |
| Stryker Corporation | $552.08 | 2025 | Artix Mt, Flowtriever, Venacore Thrombectomy Catheter |
| Shockwave Medical, INC | $350.94 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $312.16 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $288.13 | 2019-2025 | Avvigo Guidance System, Eluvia, Ranger |
| Janssen Pharmaceuticals, INC | $275.23 | 2019-2023 | Xarelto |
| Abiomed | $271.52 | 2019-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $270.43 | 2019-2025 | Jardiance |
| Pfizer INC. | $247.59 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $149.18 | 2019-2025 | Eliquis, Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $121.43 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $98.86 | 2020-2024 | Farxiga |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $84.19 | 2023-2025 | |
| Cvrx, INC. | $80.33 | 2022-2024 | Barostim Neo System |
| Kowa Pharmaceuticals America, INC. | $66.38 | 2019 | |
| Kestra Medical Technology Services, INC. | $56.70 | 2025 | Assure Wcd |
| Medtronic, INC. | $52.58 | 2022 | |
| Siemens Medical Solutions USA, INC. | $46.59 | 2022 | |
| Teleflex LLC | $40.62 | 2025 | Grebset, Guideliner |
| Biotronik INC. | $24.18 | 2019 | |
| Itamar Medical INC | $23.69 | 2022 | |
| Glaxosmithkline, LLC. | $23.57 | 2025 | Shingrix, Arexvy |
| Astellas Pharma US INC | $22.47 | 2019 | |
| Inari Medical, INC. | $22.01 | 2021 | |
| Braemar Manufacturing, LLC | $20.54 | 2019 | |
| Endologix LLC | $19.80 | 2025 | Torus Stent Graft System, Endocross Device |
| Zoll Circulation INC | $13.91 | 2023 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Philips North America LLC | $13.72 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murray Whitaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.